PLEASANTON, Calif. (AP) — PLEASANTON, Calif. (AP) — 10x Genomics Inc. (TXG) on Tuesday reported a loss of $35.8 million in its third quarter.
On a per-share basis, the Pleasanton, California-based company said it had a loss of 30 cents.
The results topped Wall Street expectations. The average estimate of eight analysts surveyed by Zacks Investment Research was for a loss of 34 cents per share.
The life science technology company posted revenue of $151.7 million in the period.
10x Genomics expects full-year revenue in the range of $595 million to $605 million.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on TXG at https://www.zacks.com/ap/TXG
Copyright © 2024 The Associated Press. All rights reserved. This material may not be published, broadcast, written or redistributed.